Alexandra W. van den Belt‐Dusebout

Late cardiotoxicity after treatment for Hodgkin lymphoma

Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Marie L. De Bruin et al. · Blood · 2006 · 766 citations · Full text

Medicine, Hematology, Oncology +12

Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Willem J. Klokman et al. · Journal of Clinical Oncology · 2003 · 717 citations

Medicine, Geriatric Medicine, Cancer Epidemiology +16

Risk of endometrial cancer after tamoxifen treatment of breast cancer

Flora E. van Leeuwen, Alexandra W. van den Belt‐Dusebout, F.E. van Leeuwen et al. · The Lancet · 1994 · 571 citations · Full text

Medicine, Gynecology, Oncology +11

Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Alexandra W. van den Belt‐Dusebout, Ronald de Wit, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2007 · 459 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

Flora E. van Leeuwen, Willem J. Klokman, Anton Hagenbeek et al. · Journal of Clinical Oncology · 1994 · 449 citations

Medicine, Oncology, Pathology +14